Evidence map›Paper›PMID 31548724›Full record

ArticleNature structural & molecular biology2019

G-tract RNA removes Polycomb repressive complex 2 from genes.

Manuel Beltran, Manuel Tavares, Neil Justin, Garima Khandelwal, John Ambrose, Benjamin M Foster, Kaylee B Worlock, Andrey Tvardovskiy, Simone Kunzelmann, Javier Herrero and 4 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role of RNA in genome folding: It's all about affinity.Current opinion in structural biology · 2025
    Review
  8. Review
  9. Review
  10. Re-analysis of CLAP data affirms PRC2 as an RNA binding protein.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Manuel BeltranUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
Manuel TavaresUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
Neil JustinThe Francis Crick Institute, London, UK.
Garima KhandelwalUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
John AmbroseUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
Benjamin M FosterInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Kaylee B WorlockUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
Andrey TvardovskiyInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Simone KunzelmannThe Francis Crick Institute, London, UK.
Javier HerreroUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.ORCID http://orcid.org/0000-0001-7313-717X
Till BartkeInstitute of Functional Epigenetics, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-6584-2140
Steven J GamblinThe Francis Crick Institute, London, UK.
Jon R WilsonThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-5157-5432
Richard G JennerUCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK. r.jenner@ucl.ac.uk.ORCID http://orcid.org/0000-0002-2946-6811
Cancer Research UK · GBThe Francis Crick Institute · GBHelmholtz Zentrum München · DE

Funding

Cancer Research UK A18088Cancer Research UK FC001078European Research Council 309952European Research Council 311704Wellcome Trust FC001078Worldwide Cancer Research 13-0256
6 · The paper itself

Abstract

Polycomb repressive complex 2 (PRC2) maintains repression of cell-type-specific genes but also associates with genes ectopically in cancer. While it is currently unknown how PRC2 is removed from genes, such knowledge would be useful for the targeted reversal of deleterious PRC2 recruitment events. Here, we show that G-tract RNA specifically removes PRC2 from genes in human and mouse cells. PRC2 preferentially binds G tracts within nascent precursor mRNA (pre-mRNA), especially within predicted G-quadruplex structures. G-quadruplex RNA evicts the PRC2 catalytic core from the substrate nucleosome. In cells, PRC2 transfers from chromatin to pre-mRNA upon gene activation, and chromatin-associated G-tract RNA removes PRC2, leading to H3K27me3 depletion from genes. Targeting G-tract RNA to the tumor suppressor gene CDKN2A in malignant rhabdoid tumor cells reactivates the gene and induces senescence. These data support a model in which pre-mRNA evicts PRC2 during gene activation and provides the means to selectively remove PRC2 from specific genes.

Indexed as

AnimalsCell LineChromatinG-QuadruplexesHistonesHumansMiceNucleosomesPolycomb Repressive Complex 2Protein BindingRNA PrecursorsTranscriptional ActivationChromatinHistonesNucleosomesPolycomb Repressive Complex 2RNA Precursors

Identifiers

PMID31548724
PMCPMC6778522
OpenAlexW2974807176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.